Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
/Modality Team Chairs, and Study Investigators. Principal Clinical Research Coordinators/Clinical Trial Portfolio Leads (CTPLs) serve as leads within their disease teams, mentoring staff, providing guidance
-
strategies including mechanisms of resistance. As a successful candidate, you will: Under minimal direction of the Principal Investigator, direct the work of a laboratory including supervision of technical lab
-
) to all applicable regulatory agencies (FDA, OBA, RAC, NIH, NCI) has been completed in a timely manner. Reviews the original protocol and all amendments, noting dates, changes in eligibility criteria, and
-
treatment approaches. As one of the largest populations of immune cells in human body and the major components of primary tumors and the metastatic sites, macrophages are key effectors mediating tumor
-
services to enhance processes, improve outcomes, and ensure patients receive the highest level of coordinated care. As a successful candidate, you will: Serve as a primary point of contact for clinical trial
-
supervision of the Principal Investigator, or designee, the RA II directs the animal work of a laboratory and/or undertakes animal (mouse) research projects in collaboration with academic supervisor, making
-
vendor agreements to ensure financial stewardship and 100% cost recovery. Ensure appropriate Non-Disclosure Agreements (NDAs), Master Service Agreements (MSAs), and contractual frameworks are in place to
-
clinical protocol development for the City of Hope Thoracic Oncology Program. Under the direction of the Division Chief, Dr. Christine Lovly, you will work closely with laboratory and clinical researchers
-
through cutting-edge research. City of Hope has a Research Associate I opportunity available. Under the direct supervision of the Principal Investigator, or designee, the Research Associate I performs a
-
, including work with primary human and murine tissues relevant to cancer and HCT. Utilize advanced laboratory techniques (e.g., flow cytometry, cell culture, immune phenotyping, molecular assays) following